Concepedia

Timothy J. Stuhlmiller

TJ

Statistics

Publications

18

Citations

1.2K

H-Index

16

Active since

2011

Affiliations

University of North Carolina at Chapel Hill(Current)

UNC Lineberger Comprehensive Cancer Center

Massachusetts General Hospital

The University of Texas MD Anderson Cancer Center

Indiana University – Purdue University Indianapolis

Timothy J. Stuhlmiller is an author at University of North Carolina at Chapel Hill specializing in molecular oncology, oncology, and medicine.

Publications per year

2011–2023

18

Publications

18

Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains

Timothy J. Stuhlmiller, Samantha M. Miller, Jon S. Zawistowski et al. · Cell Reports · 2015 · 281 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex

Jon S. Zawistowski, Samantha M. Bevill, Daniel R. Goulet et al. · Cancer Discovery · 2017 · 185 citations

Medicine, Oncology, Pharmacology +16

Molecular Pathways: Adaptive Kinome Reprogramming in Response to Targeted Inhibition of the BRAF–MEK–ERK Pathway in Cancer

Gary L. Johnson, Timothy J. Stuhlmiller, Steven P. Angus et al. · Clinical Cancer Research · 2014 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17

FGF/MAPK signaling is required in the gastrula epiblast for avian neural crest induction

Timothy J. Stuhlmiller, Martín I. García‐Castro · Development · 2011 · 90 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer

Samantha M. Bevill, José F. Olivares-Quintero, Noah Sciaky et al. · Molecular Cancer Research · 2019 · 77 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

1–5 of 18